Pharmaceutics (Sep 2020)

Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases

  • N.Vijayakameswara Rao,
  • Jun Gi Rho,
  • Wooram Um,
  • Pramod Kumar EK,
  • Van Quy Nguyen,
  • Byeong Hoon Oh,
  • Wook Kim,
  • Jae Hyung Park

DOI
https://doi.org/10.3390/pharmaceutics12100931
Journal volume & issue
Vol. 12, no. 10
p. 931

Abstract

Read online

Owing to their unique biological functions, hyaluronic acid (HA) and its derivatives have been explored extensively for biomedical applications such as tissue engineering, drug delivery, and molecular imaging. In particular, self-assembled HA nanoparticles (HA-NPs) have been used widely as target-specific and long-acting nanocarriers for the delivery of a wide range of therapeutic or diagnostic agents. Recently, it has been demonstrated that empty HA-NPs without bearing any therapeutic agent can be used therapeutically for the treatment of inflammatory diseases via modulating inflammatory responses. In this review, we aim to provide an overview of the significant achievements in this field and highlight the potential of HA-NPs for the treatment of inflammatory diseases.

Keywords